Lexaria Bioscience Corp. (NASDAQ: LEXX) Delighted About Well-Received DehydraTECH-CBD Proposals by the FDA; Maintains Late 2022/Early 2023 Target For Complete IND Application August 19, 2022
Better Choice Company Reports Record Second Quarter 2022 Gross Sales and Provides Corporate Update August 11, 2022